Maximus (NYSE:MMS) Upgraded to Buy at StockNews.com

Maximus (NYSE:MMS) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday.

Separately, Raymond James raised Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective for the company in a research note on Thursday, January 2nd.

Maximus Stock Performance

Shares of Maximus stock traded down $1.59 during trading hours on Wednesday, hitting $75.37. 755,994 shares of the company’s stock traded hands, compared to its average volume of 608,139. The stock has a market capitalization of $4.54 billion, a price-to-earnings ratio of 15.07 and a beta of 0.73. Maximus has a 12-month low of $69.72 and a 12-month high of $93.97. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.49 and a quick ratio of 1.49. The company has a fifty day simple moving average of $74.64 and a 200-day simple moving average of $84.15.

Insider Activity at Maximus

In other news, CEO Bruce Caswell acquired 3,500 shares of the business’s stock in a transaction that occurred on Tuesday, December 17th. The shares were bought at an average cost of $70.64 per share, with a total value of $247,240.00. Following the transaction, the chief executive officer now owns 275,929 shares of the company’s stock, valued at $19,491,624.56. This trade represents a 1.28 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Michelle F. Link sold 2,208 shares of Maximus stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total transaction of $163,016.64. Following the completion of the transaction, the insider now directly owns 6,567 shares of the company’s stock, valued at $484,841.61. This trade represents a 25.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have acquired a total of 7,063 shares of company stock worth $502,017 in the last 90 days. Company insiders own 1.40% of the company’s stock.

Institutional Investors Weigh In On Maximus

Several institutional investors and hedge funds have recently made changes to their positions in the company. V Square Quantitative Management LLC purchased a new stake in Maximus during the 3rd quarter valued at $25,000. UMB Bank n.a. boosted its position in shares of Maximus by 79.8% during the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock valued at $27,000 after buying an additional 158 shares during the last quarter. Eastern Bank purchased a new stake in shares of Maximus during the fourth quarter valued at $29,000. R Squared Ltd purchased a new position in Maximus in the 4th quarter worth about $54,000. Finally, GAMMA Investing LLC raised its position in Maximus by 150.6% in the 3rd quarter. GAMMA Investing LLC now owns 862 shares of the health services provider’s stock worth $80,000 after buying an additional 518 shares during the last quarter. Institutional investors own 97.21% of the company’s stock.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.